{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T23:47:52Z","timestamp":1792972072081,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["Fondecyt ID 1230475"],"award-info":[{"award-number":["Fondecyt ID 1230475"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Norepinephrine (NE) is a cornerstone drug in the management of septic shock, with its dose being used clinically as a marker of disease severity and as mortality predictor. However, variations in NE dose reporting either as salt formulations or base molecule may lead to misinterpretation of mortality risks and hinder the process of care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of the MIMIC-IV database to assess the impact of NE dose reporting heterogeneity on mortality prediction in a cohort of septic shock patients. NE doses were converted from the base molecule to equivalent salt doses, and their ability to predict 28-day mortality at common severity dose cut-offs was compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>4086 eligible patients with septic shock were identified, with a median age of 68 [57\u201378] years, an admission SOFA score of 7 [6\u201310], and lactate at\u00a0diagnosis of 3.2 [2.4\u20135.1]\u00a0mmol\/L. Median peak NE dose at day 1 was 0.24 [0.12\u20130.42]\u00a0\u03bcg\/kg\/min, with a 28-day mortality of 39.3%. The NE dose showed significant heterogeneity in mortality prediction depending on which formulation was reported, with doses reported as bitartrate and tartrate presenting 65 (95% CI 79\u201343)% and 67 (95% CI 80\u201347)% lower ORs than base molecule, respectively. This divergence in prediction widened at increasing NE doses. When using a 1\u00a0\u03bcg\/kg\/min threshold, predicted mortality was 54 (95% CI 52\u201356)% and 83 (95% CI 80\u201387)% for tartrate formulation and base molecule, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Heterogeneous reporting of NE doses significantly affects mortality prediction in septic shock. Standardizing NE dose reporting as base molecule could enhance risk stratification and improve processes of care. These findings underscore the importance of consistent NE dose reporting practices in critical care settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-024-05011-0","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T07:06:19Z","timestamp":1719990379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patients"],"prefix":"10.1186","volume":"28","author":[{"given":"Sebastian","family":"Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro D.","family":"Wendel-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Ibarra-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Retamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis I.","family":"Cort\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta Emilia","family":"Kiavialaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Ospina-Tasc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Kattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"key":"5011_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00134-021-06595-9","volume":"48","author":"J Bakker","year":"2022","unstructured":"Bakker J, Kattan E, Annane D, Castro R, Cecconi M, de Backer D, et al. Current practice and evolving concepts in septic shock resuscitation. Intensive Care Med. 2022;48:148\u201363.","journal-title":"Intensive Care Med"},{"issue":"11","key":"5011_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"issue":"4","key":"5011_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00134-024-07374-y","volume":"50","author":"E Kattan","year":"2024","unstructured":"Kattan E, Ibarra-Estrada M, Jung C. Knowing the ropes of vasopressor dosing: a focus on norepinephrine. Intensive Care Med. 2024;50(4):587\u20139.","journal-title":"Intensive Care Med"},{"key":"5011_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2024.101397","author":"I Goyer","year":"2024","unstructured":"Goyer I, Lakbar I, Freund Y, Bruno L. Norepinephrine dosing in France: time to move forward! Anaesth Crit Care Pain Med. 2024. https:\/\/doi.org\/10.1016\/j.accpm.2024.101397.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"5011_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bjae.2019.03.002","volume":"19","author":"N Desai","year":"2019","unstructured":"Desai N, Gross J. Scoring systems in the critically ill: uses, cautions, and future directions. BJA Educ. 2019;19:212\u20138. https:\/\/doi.org\/10.1016\/j.bjae.2019.03.002.","journal-title":"BJA Educ"},{"key":"5011_CR6","doi-asserted-by":"publisher","first-page":"154258","DOI":"10.1016\/j.jcrc.2023.154258","volume":"75","author":"E Antonucci","year":"2023","unstructured":"Antonucci E, Polo T, Giovini M, Girardis M, Martin-Loeches I, Nielsen ND, et al. Refractory septic shock and alternative wordings: a systematic review of literature. J Crit Care. 2023;75:154258.","journal-title":"J Crit Care"},{"key":"5011_CR7","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.accpm.2023.101193","volume":"42","author":"M Leone","year":"2023","unstructured":"Leone M, Einav S, Antonucci E, Depret F, Lakbar I, Martin-Loeches I, et al. Multimodal strategy to counteract vasodilation in septic shock. Anaesth Crit Care Pain Med. 2023;42:101193.","journal-title":"Anaesth Crit Care Pain Med."},{"key":"5011_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.chest.2022.07.018","volume":"163","author":"R Sato","year":"2023","unstructured":"Sato R, Duggal A, Sacha GL, Rudoni MA, Yataco AC, Khanna AK, et al. The relationship between norepinephrine equivalent dose of vasopressors Within 24 hours from the onset of septic shock and in-hospital mortality rate. Chest. 2023;163:148\u201351.","journal-title":"Chest"},{"key":"5011_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00134-023-07077-w","volume":"49","author":"PM Wieruszewski","year":"2023","unstructured":"Wieruszewski PM. Norepinephrine dosage: the details go beyond a grain of salt. Intensive Care Med. 2023;49:714\u20135. https:\/\/doi.org\/10.1007\/s00134-023-07077-w.","journal-title":"Intensive Care Med"},{"key":"5011_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","volume":"52","author":"PM Wieruszewski","year":"2024","unstructured":"Wieruszewski PM, Leone M, Kaas-Hansen BS, Dugar S, Legrand M, McKenzie CA, et al. Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force. Crit Care Med. 2024;52:521.","journal-title":"Crit Care Med"},{"key":"5011_CR11","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1053\/j.jvca.2023.05.013","volume":"37","author":"Y Kotani","year":"2023","unstructured":"Kotani Y, Belletti A, D\u2019Andria Ursoleo J, Salvati S, Landoni G. Norepinephrine dose should be reported as base equivalence in Clinical Research Manuscripts. J Cardiothorac Vasc Anesth. 2023;37:1523\u20134. https:\/\/doi.org\/10.1053\/j.jvca.2023.05.013.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"5011_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jcrc.2021.11.016","volume":"68","author":"E Bitton","year":"2022","unstructured":"Bitton E, Zimmerman S, Azevedo LCP, Benhamou D, Cecconi M, De Waele JJ, et al. An international survey of adherence to Surviving Sepsis Campaign Guidelines 2016 regarding fluid resuscitation and vasopressors in the initial management of septic shock. J Crit Care. 2022;68:144\u201354. https:\/\/doi.org\/10.1016\/j.jcrc.2021.11.016.","journal-title":"J Crit Care"},{"key":"5011_CR13","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2024.05.031","author":"S Salvati","year":"2024","unstructured":"Salvati S, D\u2019Andria Ursoleo J, Belletti A, Monti G, Bonizzoni MA, Fazio M, et al. Norepinephrine salt formulations and risk of therapeutic error: results of a national survey. J Cardiothorac Vasc Anesth. 2024. https:\/\/doi.org\/10.1053\/j.jvca.2024.05.031.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"5011_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07446-z","author":"E Kattan","year":"2024","unstructured":"Kattan E, Ibarra-Estrada M, Jung C. Norepinephrine dose and concentration reporting: the devil is in the details. Intensive Care Med. 2024. https:\/\/doi.org\/10.1007\/s00134-024-07446-z.","journal-title":"Intensive Care Med"},{"key":"5011_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-017-0261-x","author":"T Auchet","year":"2017","unstructured":"Auchet T, Regnier MA, Girerd N, Levy B. Outcome of patients with septic shock and high-dose vasopressor therapy. Ann Intensive Care. 2017. https:\/\/doi.org\/10.1186\/s13613-017-0261-x.","journal-title":"Ann Intensive Care"},{"key":"5011_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10:1\u20139.","journal-title":"Sci Data"},{"key":"5011_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deustchman C, Warren Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"5011_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-023-04322-y","volume":"27","author":"Y Kotani","year":"2023","unstructured":"Kotani Y, Di Gioia A, Landoni G, Belletti A, Khanna AK. An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity. Crit Care. 2023;27:1\u20137. https:\/\/doi.org\/10.1186\/s13054-023-04322-y.","journal-title":"Crit Care"},{"key":"5011_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07487-4","author":"M Ibarra-Estrada","year":"2024","unstructured":"Ibarra-Estrada M, Kattan E, Jung C. Norepinephrine dose reporting: are we looking at different sides of the same coin? Intensive Care Med. 2024. https:\/\/doi.org\/10.1007\/s00134-024-07487-4.","journal-title":"Intensive Care Med"},{"key":"5011_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00134-022-06652-x","volume":"48","author":"M Leone","year":"2022","unstructured":"Leone M, Goyer I, Levy B, D\u00fcnser MW, Asfar P, Jentzer JC. Dose of norepinephrine: the devil is in the details. Intensive Care Med. 2022;48:638\u201340. https:\/\/doi.org\/10.1007\/s00134-022-06652-x.","journal-title":"Intensive Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05011-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-024-05011-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05011-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T07:07:58Z","timestamp":1719990478000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-024-05011-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5011"],"URL":"https:\/\/doi.org\/10.1186\/s13054-024-05011-0","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,3]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Since MIMIC-IV only includes anonymized information, patients\u2019 consent to participate was waived at the local institution (Beth Israel Deaconess Medical Center (BIDMC)). Moreover, since this dataset was later made publicly available, did not require further protocol approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}